Tag: MRNA

Finance

Healthcare Decliners: Escalon Medical (NASDAQ:ESMC), CorMedix Inc. (NYSEMKT:CRMD), Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech (OTCMKTS:MRNA)

Escalon Medical Corp. (NASDAQ:ESMC) trades at a significant discount to its peer group as the lack of investor (and analyst) following results in the successful “shrink to grow” strategy being ignored. The company is now a pure play with no debt, cash that represents ~20% of the market cap, overlooked tax assets and a significantly lower cash burn rate. Escalon Medical Corp. (NASDAQ:ESMC) stock performance … Continue reading Healthcare Decliners: Escalon Medical (NASDAQ:ESMC), CorMedix Inc. (NYSEMKT:CRMD), Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech (OTCMKTS:MRNA)

Richard Atkins
Finance

Biotech Decliners: Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech, Inc. (OTCMKTS:MRNA), CorMedix Inc. (NYSEMKT:CRMD), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Ocera Therapeutics Inc (NASDAQ:OCRX) is a company with one main value driver, OCR002. Financially, the company is now sitting on $47.2 M and will be spending $30M in the 2014 financial year. It has about one year in cash. Last year, it spent $3.5M in R&D and these costs are set to increase as it ramps up the Phase 2 trials for OCR002. Ocera Therapeutics … Continue reading Biotech Decliners: Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech, Inc. (OTCMKTS:MRNA), CorMedix Inc. (NYSEMKT:CRMD), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

John Meady
BioTech

Biotech Losers: Egalet Corp (NASDAQ:EGLT), Marina Biotech (OTCMKTS:MRNA), Conatus Pharmaceuticals (NASDAQ:CNAT), Acceleron Pharma (NASDAQ:XLRN)

Egalet Corporation (NASDAQ:EGLT) announced that its fourth quarter and year ended December 31, 2013 financial results will be released on Wednesday, March 26, 2014. Egalet Corp (NASDAQ:EGLT) stock performance was -5.53% in last session and finished the day at $17.41. Traded volume was 82,789.00 shares in the last session and the average volume of the stock remained 196,859.00 shares. The beta of the stock remained … Continue reading Biotech Losers: Egalet Corp (NASDAQ:EGLT), Marina Biotech (OTCMKTS:MRNA), Conatus Pharmaceuticals (NASDAQ:CNAT), Acceleron Pharma (NASDAQ:XLRN)

Richard Atkins
BioTech

Biotech Most Volatile: Marina Biotech (OTCMKTS:MRNA), Onconova Therapeutics (NASDAQ:ONTX), OXiGENE Inc (NASDAQ:OXGN), Oragenics Inc (NYSEMKT:OGEN)

Marina Biotech, Inc. (OTCMKTS:MRNA) illustrated a similar run of events, as it reinvigorated its PR activity in the new year and shot upwards as it received a patent protection for one of its therapies. MRNA is back at $1.38, after it slumped for a while following a temporary peak at $1.70. Marina Biotech, Inc. (OTCMKTS:MRNA) stock performance was 16.67% in last session and finished the … Continue reading Biotech Most Volatile: Marina Biotech (OTCMKTS:MRNA), Onconova Therapeutics (NASDAQ:ONTX), OXiGENE Inc (NASDAQ:OXGN), Oragenics Inc (NYSEMKT:OGEN)

Chris Lewis
BioTech

Biotech Top Gainers: OXiGENE (NASDAQ:OXGN), AEterna Zentaris (NASDAQ:AEZS), Marina Biotech (OTCMKTS:MRNA), Dicerna Pharmaceuticals (NASDAQ:DRNA)

Shares of Oxigene Inc (NASDAQ:OXGN) more than doubled on very heavy volume after the microcap biotech said a mid-stage study of its drug Zybrestat, when used with Roche’s Avastin, showed increased survival in ovarian cancer patients. OXiGENE Inc (NASDAQ:OXGN) stock performance was 17.48% in last session and finished the day at $2.42. Traded volume was 6,334,713 million shares in the last session and the average … Continue reading Biotech Top Gainers: OXiGENE (NASDAQ:OXGN), AEterna Zentaris (NASDAQ:AEZS), Marina Biotech (OTCMKTS:MRNA), Dicerna Pharmaceuticals (NASDAQ:DRNA)

Jason Knox